UNH Form 4 reports disposition transactions

Zaetta Christopher R reported disposition transactions in a Form 4 filing for UNH.

Rhea-AI Filing Summary

Zaetta Christopher R reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 213 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 10,115 shares.

Insider Trade Summary

Exercise Price or Tax Liability: 212.523 shares

Exercise Price or Tax Liability 1 txn

Insider Zaetta Christopher R

Role EVP & Chief Legal Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	212.523	$293.19	$62K

Holdings After Transaction: Common Stock — 10,115.281 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UNH executive Christopher R. Zaetta report?

Christopher R. Zaetta reported a tax-withholding disposition of UnitedHealth Group common stock. On February 13, 2026, he disposed of 212.523 shares at $293.19 per share, covering tax liabilities rather than executing an open-market sale.

How many UnitedHealth Group (UNH) shares were involved in Zaetta’s Form 4 filing?

The filing reports 212.523 shares of UnitedHealth Group common stock. These shares were disposed of at $293.19 per share as part of a tax-withholding disposition, a mechanism to satisfy tax obligations tied to equity compensation.

What does transaction code F mean in the UNH insider filing for Zaetta?

Transaction code F indicates a tax-withholding disposition. It reflects the payment of an exercise price or tax liability by delivering securities, rather than a discretionary buy or sell in the open market by the reporting insider.

How many UNH shares does Christopher R. Zaetta own after the reported transaction?

Following the reported transaction, Christopher R. Zaetta beneficially owned 10,115.281 shares of UnitedHealth Group common stock. These holdings are reported as direct ownership, meaning the shares are held in his own name rather than through an intermediary entity.

Was the UNH insider transaction by Zaetta a market sale of shares?

The transaction was reported as a tax-withholding disposition, not an open-market sale. Code F and the description indicate shares were delivered to cover tax or exercise obligations associated with equity compensation, rather than a discretionary sale for investment purposes.

What role does Christopher R. Zaetta hold at UnitedHealth Group (UNH)?

Christopher R. Zaetta is reported as an Officer of UnitedHealth Group, serving as EVP & Chief Legal Officer. His Form 4 filing reflects transactions in company common stock associated with this executive position and related equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zaetta Christopher R

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		212.523	D	$293.19	10,115.281	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Christopher R. Zaetta	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.